Clinical trials
Phase 3 Lipid Metabolism Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2014 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kastle Therapeutics, LLC | 2 |
| 89bio, Inc. | 1 |
| Amgen | 1 |
| Arrowhead Pharmaceuticals | 1 |
| King Edward Medical University | 1 |
| NewAmsterdam Pharma | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dyslipidemias | 7 |
| Lipid Metabolism Disorders | 7 |
| Metabolic Diseases | 6 |
| Hyperlipidemias | 5 |
| Genetic Diseases, Inborn | 4 |
| Hypercholesterolemia | 4 |
| Hyperlipoproteinemia Type II | 4 |
| Hyperlipoproteinemias | 4 |
| Lipid Metabolism, Inborn Errors | 4 |
| Homozygous Familial Hypercholesterolemia | 3 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.